Eximore Ltd is an innovative biopharmaceutical company dedicated to the development and commercialization of our proprietary "Pack and Release" punctal plug technology for the treatment of ocular diseases.
We are positioned to become a transformative force in the ophthalmic space by revolutionizing drug delivery. Our solutions simplify the complex and burdensome eye drop regimen by offering a non-invasive, sustained-release alternative, addressing a critical need in eye care.
With a strategic focus on advancing our glaucoma and dry eye treatments through Phase 2 clinical trials, Eximore is committed to improving patient adherence and compliance. Our goal is to deliver consistent, reliable drug dosing, ultimately ensuring better patient outcomes and redefining the standard of care in ophthalmology.
Company Details
- Employees
- 7
- Founded
- -
- Address
- Ha-Rav Shalom Shabazi St 26,, Rosh Haayin,israel
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://eximore.co.il/
- HQ
- Rosh Haayin
Eximore Questions
Eximore's website is https://eximore.co.il/
Eximore's LinkedIn profile is https://il.linkedin.com/company/eximore
Eximore has
7 employees.
View email and phone details for 7
employees at Eximore.
Eximore's industry is
Pharmaceutical Manufacturing
Eximore's top competitors are
Maicelium Biomaterials,
Append Medical,
Franklin By Qiagen,
Plantarcbio,
Virusight Diagnostic,
Vocavibe,
Brainstorm Cell Therapeutics,
Nrgene Ltd.,
Bioweez,
Lutris Pharma.
Eximore's categories are Pharmaceutical Manufacturing
Eximore's founding year is 2013
